Scinai Immunotherapeutics Ltd.
SCNI
$2.44
-$0.0734-2.92%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -23.45% | -15.24% | -30.49% | -30.49% | -23.28% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -68.86% | 65.22% | 15.97% | 15.97% | 164.44% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 14.75% | -3.17% | -0.79% | -0.79% | -9.29% |
| Total Current Assets | -18.85% | -13.62% | -29.65% | -29.65% | -23.14% |
|
|
|||||
| Total Current Assets | -18.85% | -13.62% | -29.65% | -29.65% | -23.14% |
| Net Property, Plant & Equipment | 1.31% | -2.12% | -0.98% | -0.98% | -3.54% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -5.97% | -6.61% | -14.58% | -14.58% | -13.95% |
|
|
|||||
| Total Accounts Payable | -2.01% | -16.13% | -50.42% | -50.42% | 83.38% |
| Total Accrued Expenses | 39.18% | -27.64% | -0.35% | -0.35% | -31.77% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.66% | -3.05% | -6.19% | -6.19% | 9.95% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 15.73% | -18.54% | -26.79% | -26.79% | 10.31% |
|
|
|||||
| Total Current Liabilities | 15.73% | -18.54% | -26.79% | -26.79% | 10.31% |
| Long-Term Debt | 4.12% | -20.14% | 6.59% | 6.59% | 8.81% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -3.16% | -11.22% | -8.04% | -8.04% | -6.49% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -69.13% | -65.52% | -66.14% | -66.14% | -50.01% |
| Total Liabilities | 3.61% | -21.23% | -3.89% | -3.89% | -2.52% |
|
|
|||||
| Common Stock & APIC | 0.38% | 1.12% | 1.12% | 1.12% | 0.30% |
| Retained Earnings | -1.94% | 2.52% | -3.15% | -3.15% | -3.03% |
| Treasury Stock & Other | 0.00% | 0.00% | 7.99% | 7.99% | 5.78% |
| Total Common Equity | -69.73% | 62.15% | -47.86% | -47.86% | -173.30% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -69.73% | 62.15% | -47.86% | -47.86% | -173.30% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -69.73% | 62.15% | -47.86% | -47.86% | -173.30% |
|
|
|||||